药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cinolazepam
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydrocortisone butyrate.
Cinolazepam
Roflumilast
Roflumilast may increase the immunosuppressive activities of Hydrocortisone butyrate.
Cinolazepam
Difluocortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Hydrocortisone butyrate.
Cinolazepam
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hydrocortisone butyrate.
Cinolazepam
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Hydrocortisone butyrate.
Cinolazepam
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone butyrate.
Cinolazepam
Bleselumab
The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Bleselumab.
Cinolazepam
Rozanolixizumab
The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Rozanolixizumab.
Cinolazepam
Risankizumab
The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Risankizumab.
Cinolazepam
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Hydrocortisone succinate.
Cinolazepam
Mometasone furoate
The risk or severity of adverse effects can be increased when Mometasone furoate is combined with Hydrocortisone butyrate.
Cinolazepam
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Monomethyl fumarate is combined with Hydrocortisone butyrate.
Cinolazepam
Fluclorolone
The risk or severity of adverse effects can be increased when Fluclorolone is combined with Hydrocortisone butyrate.
Cinolazepam
Cloprednol
The risk or severity of adverse effects can be increased when Cloprednol is combined with Hydrocortisone butyrate.
Cinolazepam
Fluperolone
The risk or severity of adverse effects can be increased when Fluperolone is combined with Hydrocortisone butyrate.
Cinolazepam
Begelomab
The risk or severity of adverse effects can be increased when Begelomab is combined with Hydrocortisone butyrate.
Cinolazepam
Fluocortin
The risk or severity of adverse effects can be increased when Fluocortin is combined with Hydrocortisone butyrate.
Cinolazepam
Prednylidene
The risk or severity of adverse effects can be increased when Prednylidene is combined with Hydrocortisone butyrate.
Cinolazepam
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when 9-(N-methyl-L-isoleucine)-cyclosporin A is combined with Hydrocortisone butyrate.
Cinolazepam
Hypericin
The risk or severity of adverse effects can be increased when Hypericin is combined with Hydrocortisone butyrate.